Elliott Vichinsky, MD: Voxelotor and New HOPE Data
Dec 08, 2020, 11:48 PM
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
You can visit our support center if you're having problems.